NEUROENDOCRINE CANCER
Clinical trials for NEUROENDOCRINE CANCER explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE CANCER trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo aims to tackle Treatment-Resistant cancers
Disease control Not yet recruitingThis early-stage trial tests whether an experimental drug called TLN-499, combined with the approved cancer drug venetoclax, is safe and tolerable for people with certain advanced solid tumors that have stopped responding to standard treatments. The study includes adults with sma…
Matched conditions: NEUROENDOCRINE CANCER
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat gut tumors
Disease control Not yet recruitingThis phase 2 trial tests a new drug called ivonescimab (AK112) combined with chemotherapy (irinotecan and cisplatin) for people with metastatic digestive system neuroendocrine cancer that has spread. Some participants also receive a procedure called TACE, which blocks blood flow …
Matched conditions: NEUROENDOCRINE CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC